NCT05806346View on ClinicalTrials.gov

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

NARecruitingINTERVENTIONAL
Enrollment

764

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

June 30, 2025

Conditions
Heart DiseasesVascular DiseasesTransfusion Related ComplicationCoagulation Disorder, BloodFibrinolysis; Hemorrhage
Interventions
DRUG

TXA administration

Tranexamic acid intravenous administration

DRUG

Placebo administration

Placebo (normal saline) intravenous administration

Trial Locations (3)

05030

RECRUITING

Konkuk University Medical Center, Seoul

06351

RECRUITING

Samsung Medical Center, Seoul

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Korea Health Industry Development Institute

OTHER_GOV

collaborator

Helptrial

UNKNOWN

collaborator

Asan Medical Center

OTHER

collaborator

Samsung Medical Center

OTHER

lead

Konkuk University Medical Center

OTHER

NCT05806346 - Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery | Biotech Hunter | Biotech Hunter